To include your compound in the COVID-19 Resource Center, submit it here.

Assembly, Allergan deal

Assembly granted Allergan exclusive, worldwide rights to preclinical candidates ABI-M201, which is in development for ulcerative colitis; and

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE